Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal ... Manufacturing Digital (press release) The most common adverse reactions (>5%) included: nausea, headache, application site pruritus, dizziness, constipation, somnolence, vomiting, application site erythema, dry mouth, and application site rash. Three strengths of Butrans are commercially ... |
Category Archives: Pruritus
BAXTER INTERNATIONAL INC. : Baxter Announces ADVATE Approval in China for the … – 4-traders
BAXTER INTERNATIONAL INC. : Baxter Announces ADVATE Approval in China for the ... 4-traders Symptoms have manifested as dizziness, paresthesia, rash, flushing, face swelling, urticaria, dyspnea, and pruritus. Discontinue use if hypersensitivity symptoms occur and administer appropriate emergency treatment. Carefully monitor patients treated ... |